EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Elevated mortality and upregulated SARS-CoV-2-associated pathways in innate and adaptive immune cells from individuals with Down syndrome

Daniella Balduino Victorino, Jackeline Moraes Malheiros, Felipe Ten-Caten, Victor Hugo Cardoso Betta, Felipe Farinha Saad Barbosa, Khader Ghneim, Fernanda Caroline Coirada, Fernanda Romano Bruno, Giuliana Xavier de Medeiros, Cassia Silveira, Christina Gavegnano, Robert Balderas und 6 weitere

PLOS One · 2026

DOI: 10.1371/journal.pone.0338519 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Daniella Balduino Victorino und 17 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, AP-HP, Hôpital de la Pitié Salpêtrière, Paris, France. Hauptthemen laut MEDLINE: Down Syndrome, COVID-19, SARS-CoV-2, Adaptive Immunity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Trisomy 21 increases the risk of severe outcomes and mortality in hospitalized individuals with Down syndrome (DS) following SARS-CoV-2 infection. Using data from the Brazilian Epidemiological Surveillance Information System Influenza (SIVEP-Gripe), we analyzed 102,767 hospitalized COVID-19 patients (1,115 DS and 101,652 non-DS, NDS). DS patients had a higher prevalence of comorbidities and required ventilatory support, ICU admission, and intubation more frequently than NDS patients (p < 0.001). Mortality was 4.5 times higher in DS patients aged 0–30 years (26.3% vs. 5.9%, p < 0.001) and remained 2.22 times higher after adjusting for comorbidities. DS patients over 30 years also exhibited a 22% increase in mortality (PR 1.22, p < 0.001). Gene expression analysis of pre-pandemic monocytes and T cells from DS individuals revealed upregulated pathways linked to SARS-CoV-2 infection, including interferon signaling and cytokine interactions. This baseline immune dysregulation may contribute to severe COVID-19 outcomes in DS patients. Identifying these altered pathways could inform targeted therapeutic strategies to improve immune homeostasis and clinical outcomes. To the best of our knowledge, this is the first study integrating nationwide clinical outcomes with pre-pandemic immune transcriptomic data to mechanistically explain the heightened COVID-19 severity in individuals with DS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Down SyndromeCOVID-19SARS-CoV-2Adaptive ImmunityImmunity, InnateHumansMaleFemaleChild, PreschoolInfantAdultChildAdolescentYoung AdultMiddle AgedBrazilInfant, NewbornUp-RegulationMonocytesT-Lymphocytes

Autor:innen und Institutionen

  • Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, AP-HP, Hôpital de la Pitié Salpêtrière, Paris, France.
  • Department of Physiology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil.
  • Pathology Advanced Translational Research Unit (PATRU), Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, Georgia, United States of America.
  • Department of Infectious and Parasitic Diseases, School of Medicine, University of São Paulo, São Paulo, Brazil.
  • Atlanta VÁ Medical Center, Atlanta, Georgia, United States of America.
  • Emory University Department of Pathology, Atlanta, Georgia, United States of America.

ORCID-Profile: Susan Pereira Ribeiro

Zitieren

APA

Victorino, D. B., Malheiros, J. M., Ten-Caten, F., Cardoso Betta, V. H., Barbosa, F. F. S., Ghneim, K., Coirada, F. C., Bruno, F. R., de Medeiros, G. X., Silveira, C., Gavegnano, C., Balderas, R., Brandao, A. C., Yang, E., Nakaya, H., Wagner, G. A., Covolan, L., & Pereira Ribeiro, S. (2026). Elevated mortality and upregulated SARS-CoV-2-associated pathways in innate and adaptive immune cells from individuals with Down syndrome. PLOS One. https://doi.org/10.1371/journal.pone.0338519

Vancouver

Victorino DB, Malheiros JM, Ten-Caten F, Cardoso Betta VH, Barbosa FFS, Ghneim K, et al. Elevated mortality and upregulated SARS-CoV-2-associated pathways in innate and adaptive immune cells from individuals with Down syndrome. PLOS One. 2026. doi:10.1371/journal.pone.0338519

BibTeX
@article{Victorino2026,
  author = {Victorino, Daniella Balduino and Malheiros, Jackeline Moraes and Ten-Caten, Felipe and Cardoso Betta, Victor Hugo and Barbosa, Felipe Farinha Saad and Ghneim, Khader and Coirada, Fernanda Caroline and Bruno, Fernanda Romano and de Medeiros, Giuliana Xavier and Silveira, Cassia and Gavegnano, Christina and Balderas, Robert and Brandao, Ana Claudia and Yang, Edward and Nakaya, Helder and Wagner, Gabriela A and Covolan, Luciene and Pereira Ribeiro, Susan},
  title = {Elevated mortality and upregulated SARS-CoV-2-associated pathways in innate and adaptive immune cells from individuals with Down syndrome},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0338519}
}
Kostenlos starten →